Status
Conditions
Treatments
About
The primary objective of this study will be to study the correlation between implant position (malposition), evaluated through periapical radiographs of peri-implantitis vs healthy implants, and the occurrence of peri-implant biological complications such as peri-implantitis, as evaluated after at least 6 months from the placement of the prosthesis. The clinical records of all subjects treated with implants during the period between January 1st, 2005, and June 30th, 2021 (last follow-up included: 6 month visit on December 2021) in the Dental Clinic of the IRCCS Istituto Ortopedico Galeazzi (Milan, Italy) will be screened for inclusion.
Will be included 45 implants with peri-implantitis and 135 healthy implants regardless of the corresponding number of patients . Descriptive statistics will be provided by means of mean values and standard deviations. Correlation between baseline parameters and outcomes will be measured through regression analysis, being the independent variable the occurrence of peri-implantitis. Multilevel analysis will be performed.
For all the analysis, the level of significance was set at p<0.05.
For sample size calculation the investigators have considered alpha = .05, power = 80% and a proportion between controls and cases of 3:1. The investigators hypothesized a detection of an effect of malposition with a proportion of 0.25 of exposes in control group and 0.5 in test group. the investigators decided to include 45 implants with peri-implantitis and 135 healthy implants, after augmenting the numbers hypothesizing a maximum of 10% dropouts. The proportion of exposed are estimated on the basis of the study published by Yi et al. in 2020 .
The calculation was performed using the method proposed by Schoenfeld.
Full description
The primary outcome was the occurrence of peri-implantitis described as:
Implant malposition will be defined on the basis of the following parameters:
The following parameters will be collected from clinical records:
Clinical data will be completely anonymized through the association of each subject to one identification code, and the elimination of the document containing the link between them.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
130 participants in 2 patient groups
Loading...
Central trial contact
Stefano Corbella, PhD, Researcher; benedetta morandi
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal